Corbus Pharmaceuticals Holdings, Inc. (0SZI.L) LSE

12.17

+0.2294(+1.92%)

Updated at September 29 06:48PM

Currency In USD

Valuation

Market Cap128.8M
Enterprise Value114.84M
P/E Ratio-2.59
PEG Ratio-0.08
Price/Sales Ratio213.61
Price/Book Ratio1.35
Enterprise/Revenue188.61
Enterprise/EBITDA-2.32

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin-82.39
Operating Margin-95.31

Management Effectiveness

Return On Assets-0.46
Return On Equity-0.44

Income Statement

Revenue0
Revenue/Share0.06
Gross Profit-600,000
EBITDA-37.74M
Net Income-40.21M
Diluted EPS-3.68

Balance Sheet

Total Cash20.04M
Total Cash/Share9.53
Total Debt2.46M
Total Debt/Equity0.02
Current Ratio9.21
Book Value Per Share9.07

Price History

52-Week Change-41.94
52-Week High49.65
52-Week Low2.82
Moving Average 50 Days21.54
Moving Average 200 Days10.76

Statistics

Average Volume3,322
Shares Outstanding12.25M
% Held by Institutions78.36

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:30
Last Split DateFebruary 23, 2023